Please enable JavaScript in your browser. 
Skip to main content
Drug Information Portal National Library of Medicine
       Home    Substance
Drug Name: Pexelizumab [USAN:INN:BAN]
Description: A 25 kDa recombinant, humanized, single-chain antibody that binds to human C5 with a very high affinity & thereby blocks C5 cleavage by C5 convertases. 

Site Map, Contact Us, Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act
Drug Information Portal Mobile Site
Last updated: Jan 2019